Concepedia

Natalia Allende Burgos

NA

Statistics

Publications

2

Citations

482

H-Index

2

Active since

2023

Affiliations

Therapeutics Clinical Research(Current)

The Ohio State University Wexner Medical Center

University of Michigan

Natalia Allende Burgos is an author at Therapeutics Clinical Research specializing in immune-mediated renal disease, immunoglobulin a nephropathy, and renal pathophysiology.

Publications per year

2023–2023

2

Publications

2

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Donald Brandon, Natalia Allende Burgos et al. · The Lancet · 2023 · 267 citations · Full text

, , +9

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

, , +12

1–2 of 2